Results 101 to 110 of about 17,376 (176)

Perioperative Outcomes of Nephrectomy for Autosomal Dominant Polycystic Kidney Disease. [PDF]

Urol Pract
Bacchus MW, Wong V, Sood A, Singer EA, Dason S.   +4 more
europepmc   +1 more source

Health-related quality of life in people with autosomal dominant polycystic kidney disease: a systematic review. [PDF]

Clin Kidney J
Gittus M, Zhang Y, Harnan S, Sutton A, Fotheringham J, Ong ACM, Mandrik O.   +6 more
europepmc   +1 more source

The Relationship of Osmolality and Kidney Outcomes in Patients with Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360
Fung WW, Szeto CC, Chow KM, Chao AC, Kwong VW, Lau SL, Pang WF, Sin HK, Ho E, Kwan LP, Chan KM, Shum GT, Hau AK, Chan KL, Lin RC, Kwok LM, Yuen SK, Lui SL, Fung SK, Wong S, Chu WC, Ong ACM, Devuyst O, Li PK, On behalf of the CysticHK cohort collaborators.   +24 more
europepmc   +1 more source

A case of autosomal dominant polycystic kidney disease with multiple bilateral spontaneous retroperitoneal hemorrhages. [PDF]

CEN Case Rep
Mizuta M, Suwabe T, Oba Y, Sekine A, Yamanouchi M, Mizuno H, Hasegawa E, Wada T, Fukuda M, Miyazono M, Sawa N, Ubara Y.   +11 more
europepmc   +1 more source

Epithelial Dynamics of Cystogenesis in Genetic Models of Autosomal Dominant Polycystic Kidney Disease. [PDF]

Cells
Sun M, Wu Z, Hu M, Luo W, Chen X, Ma M.
europepmc   +1 more source

Role of Mediterranean Diet Adherence on Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease Patients. [PDF]

Biomolecules
Salomone L, Menichelli D, Cammisotto V, Castellani V, Pastori D, Pignatelli P, Mitterhofer AP, Tinti F, Lai S.   +8 more
europepmc   +1 more source

Tolvaptan pharmacokinetics and pharmacodynamics in adolescents with autosomal dominant polycystic kidney disease. [PDF]

Eur J Pediatr
Shoaf SE, Sikes K.
europepmc   +1 more source

Refining Tolvaptan Dosing in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney360
Dahl NK, Torres VE.
europepmc   +1 more source

Association of 24-hour urinary parameters with renal function and other comorbidities in autosomal dominant polycystic kidney disease. [PDF]

BMC Nephrol
Aykut H, Alışır Ecder S, Ecder T.
europepmc   +1 more source

Feasibility Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease: Design and Baseline Characteristics. [PDF]

Am J Nephrol
Seliger SL, Wang W, Watnick T, George D, Diggs C, West M, Nowak K, Ostrow A, You Z, Gitomer B, Chonchol M.   +10 more
europepmc   +1 more source